Search | TVST | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of ophthalmic mitochondrial reactive oxygen species scavenger Visomitin for the treatment of dry eye disease: findings of VISTA-1 and VISTA-2 studies

George W Ousler; Michael Watson; John D Sheppard; Paul Karpecki; Lawrence T. Friedhoff; Anton Petrov; Maxim Skulachev; Malcolm Ngiam; Quinn Xue

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1555 – A0280.

Clinical Trials November 2020

Novel Extranasal Tear Stimulation: Pivotal Study Results

PDF

Marco H. Ji; Darius M. Moshfeghi; Laura Periman; David Kading; Cynthia Matossian; Gerald Walman; Scott Markham; Andy Mu; Ann Jayaram; Michael Gertner; Paul Karpecki; Neil J. Friedman

Trans. Vis. Sci. Tech.. 2020; 9(12):23. https://doi.org/10.1167/tvst.9.12.23

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Effect of cyclosporine ophthalmic solution 0.09% on conjunctival staining in patients with keratoconjunctivitis sicca

Abayomi B Ogundele; Paul Karpecki; Douglas Devries; Charles Darby; Jodi Luchs

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):115.

ARVO Annual Meeting Abstract June 2020

Phentolamine mesylate ophthalmic solution reduces time to recovery of medically-induced mydriasis in a Phase 2 trial

Paul Karpecki; Bill Pitlick; Alan Meyer; Mina Sooch; Reda Jaber; Konstantinos Charizanis; Eliot Lazar; Charles Slonim; Marguerite McDonald

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2667.

ARVO Annual Meeting Abstract June 2015

Assessment of quality of life and symptom reduction in dry eye subjects using Retaine™ Ophthalmic Emulsion

Michael Watson; George W Ousler; Douglas Devries; Paul Karpecki; Joseph B Ciolino

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4483.

Advertisement